Literature DB >> 15104335

Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats.

Barbara Musi1, Magnus Braide, Ola Carlsson, Anders Wieslander, Ann Albrektsson, Markus Ketteler, Ralf Westenfeld, Jürgen Floege, Bengt Rippe.   

Abstract

OBJECTIVES: Long-term peritoneal dialysis (PD) leads to structural and functional changes in the peritoneum. The aim of the present study was to investigate the long-term effects of PD fluid components, glucose and glucose degradation products (GDP), and lactate-buffered solution on morphology and transport characteristics in a nonuremic rat model.
METHODS: Rats were subjected to two daily intraperitoneal injections (20 mL/day) during 12 weeks of one of the following: commercial PD fluid (Gambrosol, 4%; Gambro AB, Lund, Sweden), commercial PD fluid with low GDP levels (Gambrosol trio, 4%; Gambro AB), sterile-filtered PD fluid (4%) without GDP, or a glucose-free lactate-buffered PD fluid. Punctured and untreated controls were used. Following exposure, the rats underwent a single 4-hour PD dwell (30 mL, 4% glucose) to determine peritoneal function. Additionally, submesothelial tissue thickness, percentage of high mesothelial cells (perpendicular diameter > 2 microm), vascular density, vascular endothelial growth factor (VEGF), and transforming growth factor (TGF) beta1 mRNA expression were determined. Submesothelial collagen concentration was estimated by van Gieson staining.
RESULTS: Submesothelial tissue thickness and vascular density, mediated by VEGF and TGFbeta production, in the diaphragmatic peritoneum increased significantly in rats exposed to any PD fluid. Gambrosol induced a marked increased fibrosis of the hepatic peritoneum. A significant increase in high mesothelial cells was observed in the Gambrosol group only. Net ultrafiltration was reduced in the Gambrosol and in the glucose-free groups compared to untreated controls. Small solute transport was unchanged, but all groups exposed to fluids showed significantly increased lymph flow.
CONCLUSIONS: Our results show that long-term exposure to different components of PD fluids leads to mesothelial cell damage, submesothelial fibrosis, and neoangiogenesis. Mesothelial cell damage could be connected to the presence of GDP; the other changes were similar for all fluids. Peritoneal transport characteristics did not change in any consistent way and the neoangiogenesis observed was not paralleled by increased solute transport.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104335

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  10 in total

1.  Chronic infusion of sterile peritoneal dialysis solution abrogates enhanced peritoneal gene expression responses to chronic peritoneal catheter presence.

Authors:  El Rasheid Zakaria; Paul J Matheson; Ryan T Hurt; Richard N Garrison
Journal:  Adv Perit Dial       Date:  2008

Review 2.  A review of rodent models of peritoneal dialysis and its complications.

Authors:  Ji Wang; Shujun Liu; Hongyu Li; Jing Sun; Sijin Zhang; Xiaohong Xu; Yingying Liu; Yangwei Wang; Lining Miao
Journal:  Int Urol Nephrol       Date:  2014-11-26       Impact factor: 2.370

3.  A new neutral-pH low-GDP peritoneal dialysis fluid.

Authors:  Rainer Himmele; Lynn Jensen; Dominik Fenn; Chih-Hu Ho; Dixie-Ann Sawin; Jose A Diaz-Buxo
Journal:  Perit Dial Int       Date:  2012-03-01       Impact factor: 1.756

Review 4.  Pharmacologic targets and peritoneal membrane remodeling.

Authors:  Karima Farhat; Andrea W D Stavenuiter; Rob H J Beelen; Piet M Ter Wee
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

5.  Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan.

Authors:  Nobuhiro Ayuzawa; Yoshitaka Ishibashi; Yutaka Takazawa; Haruki Kume; Toshiro Fujita
Journal:  Perit Dial Int       Date:  2011-07-31       Impact factor: 1.756

6.  Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis.

Authors:  Yanyan Sun; Fengxin Zhu; Xueqing Yu; Jing Nie; Fengxian Huang; Xiaoyan Li; Ning Luo; Hui Yao Lan; Yongtao Wang
Journal:  Am J Nephrol       Date:  2009-02-18       Impact factor: 3.754

7.  The effect of statin on epithelial-mesenchymal transition in peritoneal mesothelial cells.

Authors:  Tae Ik Chang; Hye-Young Kang; Kyung Sik Kim; Sun Ha Lee; Bo Young Nam; Jisun Paeng; Seonghun Kim; Jung Tak Park; Tae-Hyun Yoo; Shin-Wook Kang; Seung Hyeok Han
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

8.  Protection of the Peritoneal Membrane by Peritoneal Dialysis Effluent-Derived Mesenchymal Stromal Cells in a Rat Model of Chronic Peritoneal Dialysis.

Authors:  Lan Zhou; Ming Zong; Qiunong Guan; Gerald da Roza; Hao Wang; Hualin Qi; Caigan Du
Journal:  Stem Cells Int       Date:  2019-09-16       Impact factor: 5.443

9.  Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis.

Authors:  Zhenghong Li; Lu Zhang; Weiming He; Changle Zhu; Jinsong Yang; Meixiao Sheng
Journal:  Int J Mol Sci       Date:  2014-07-22       Impact factor: 5.923

10.  Newly designed Protein Transduction Domain (PTD)-mediated BMP-7 is a potential therapeutic for peritoneal fibrosis.

Authors:  Seonghun Kim; Dong Ho Shin; Bo Young Nam; Hye-Young Kang; Jimin Park; Meiyan Wu; Nam Hee Kim; Hyun Sil Kim; Jung Tak Park; Seung Hyeok Han; Shin-Wook Kang; Jong In Yook; Tae-Hyun Yoo
Journal:  J Cell Mol Med       Date:  2020-10-20       Impact factor: 5.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.